Core Scientific Files 8-K: Financials & Reg FD

Ticker: CORZR · Form: 8-K · Filed: Oct 15, 2025 · CIK: 1839341

Core Scientific, Inc./Tx 8-K Filing Summary
FieldDetail
CompanyCore Scientific, Inc./Tx (CORZR)
Form Type8-K
Filed DateOct 15, 2025
Risk Levelmedium
Pages4
Reading Time5 min
Key Dollar Amounts$0.00001, $6.81, $0.01
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, regulation-fd, corporate-actions

TL;DR

Core Scientific dropped an 8-K on Oct 15th – check financials and Reg FD updates.

AI Summary

Core Scientific, Inc. filed an 8-K on October 15, 2025, reporting on Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Power & Digital Infrastructure Acquisition Corp., is incorporated in Delaware and has its principal executive offices in Dover, DE.

Why It Matters

This filing provides crucial updates on Core Scientific's financial status and regulatory compliance, which are important for investors to assess the company's current standing and future prospects.

Risk Assessment

Risk Level: medium — The filing is a standard 8-K for financial reporting and regulatory disclosure, but the nature of the financial statements and exhibits could reveal underlying risks.

Key Numbers

  • 001-40046 — SEC File Number (Identifies the company's filing with the SEC)
  • 86-1243837 — IRS Employer Identification No. (Tax identification number for the company)

Key Players & Entities

  • Core Scientific, Inc. (company) — Registrant
  • Power & Digital Infrastructure Acquisition Corp. (company) — Former company name
  • October 15, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • Dover, DE (location) — Business and mail address city and state

FAQ

What specific financial statements or exhibits are being reported in this 8-K filing?

The filing explicitly mentions 'Financial Statements and Exhibits' as an item of information, but the specific details of these documents are not provided in the header information.

What is the significance of the 'Regulation FD Disclosure' item?

Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, so this item indicates the company is adhering to these disclosure rules.

When did Core Scientific, Inc. change its name from Power & Digital Infrastructure Acquisition Corp.?

The filing indicates the date of the name change was January 6, 2021.

What is the exercise price for the warrants mentioned in the filing?

The filing mentions warrants with an exercise price of $0.01 per share and others with an exercise price of $6.81 per share.

Where are Core Scientific, Inc.'s principal executive offices located?

The company's business and mail address is listed as 838 Walker Road, Suite 21-2105, Dover, DE 19904.

Filing Stats: 1,335 words · 5 min read · ~4 pages · Grade level 12.1 · Accepted 2025-10-15 16:45:30

Key Financial Figures

  • $0.00001 — ich registered Common stock, par value $0.00001 per share CORZ The Nasdaq Global Se
  • $6.81 — of common stock at an exercise price of $6.81 per share CORZW The Nasdaq Global S
  • $0.01 — of common stock at an exercise price of $0.01 per share CORZZ The Nasdaq Global S

Filing Documents

01

Item 7.01. Regulation FD Disclosure. Core Scientific, Inc. (" Core Scientific ") updated its investor presentation, which representatives of Core Scientific may present to certain investors, analysts and proxy advisory firms from time-to-time (the " Investor Presentation ") in connection with the upcoming special meeting of Core Scientific stockholders (the " Special Meeting ") to consider and vote upon a proposal to adopt the Agreement and Plan of Merger, dated as of July 7, 2025, by and among Core Scientific, CoreWeave, Inc. (" CoreWeave ") and Miami Merger Sub I, Inc., and certain other related matters. The Special Meeting is scheduled to be held on October 30, 2025. A copy of the Investor Presentation is being furnished as Exhibit 99.1 hereto and incorporated into this Item 7.01 by reference. The information in this Item 7.01 (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filings under the Securities Act of 1933, as amended (the " Securities Act "), or the Exchange Act, except as may be expressly set forth by specific reference in such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1+ Investor Presentation, dated October 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). + Furnished herewith. Important Information about the Transaction and Where to Find It In connection with the proposed transaction between Core Scientific and CoreWeave, Core Scientific and CoreWeave filed with the SEC a registration statement on Form S-4 on August 20, 2025, which was amended on September 17, 2025 and September 25, 2025, that includes a proxy statement of Core Scientific that also constitutes a prospectus of CoreWeave. The registration statement on Form S-4 was declared effective on September 26, 2025. CoreWeave filed a prospectus on September 26, 2025, and Core Scientific filed a definitive proxy statement on September 26, 2025. Each of Core Scientific and CoreWeave may also file other relevant documents with the SEC regarding the proposed transaction. This communication is not a substitute for the registration statement, proxy statement or prospectus or any other document that Core Scientific or CoreWeave (as applicable) has filed or may file with the SEC in connection with the proposed transaction. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND SECURITY HOLDERS OF CORE SCIENTIFIC AND COREWEAVE ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND RELATED MATTERS. Investors and security holders may obtain free copies of the registration statement and the proxy statement/prospectus, as well as other filings containing important information about Core Scientific or CoreWeave, without charge at the SEC's Internet w

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.